PBM Transparency Rule Finalized as CMS and HHS Push Drug Pricing Reform
CMS and HHS moved on breast cancer screening, PBM transparency and RHTP funding, with a finalized rule aimed at drug pricing accountability.
This section contains the website’s posts.